Biosimilar
A biological product highly similar to an already approved reference biologic with no clinically meaningful differences in safety, purity, or potency. Follows abbreviated regulatory pathway (351(k) in US).
Exemples
- Adalimumab biosimilars
- Trastuzumab biosimilars
- Interchangeable biosimilars
Le saviez-vous ?
A biological product highly similar to an already approved reference biologic with no clinically meaningful differences in safety, purity, or potency. Follows abbreviated regulatory pathway (351(k) in US).